Intraabdominal hypertension (IAH) and the abdominal compartment syndrome (ACS) are caused by a systemic inflammatory response in concert with aggressive fluid resuscitation. The syndrome affects a broad spectrum of critically ill patients ranging from severe sepsis to major trauma. Attendees will leave with an in-depth understanding of the pathophysiology of intra-abdominal hypertension– why capillary leak caused by indiscriminate inflammatory response impacts almost every organ in the body – as well as insights into the many bedside medical interventions that can be undertaken to achieve improved outcomes and reduced resource utilization. Finally, they will also be exposed to cost analysis data from recent clinical trials demonstrating both increased survival and decreased resource utilization when IAH is detected early and aggressively treated with medical and surgical therapies.
This program has been designed for a multidisciplinary physician and nurse audience including: ICU / Anesthesia / Peri-op / Intensivists / Trauma / Critical Care
This program is supported by an educational grant from Wolf-Tory, a manufacturer of Medical Devices.
Release Date: July 01, 2009 -- Expiration Date: June 30, 2011
Faculty: Timothy R. Wolfe, M.D.
By the end of the session the participant will be able to:
As an accredited provider of continuing medical education, it is the policy of the IMS to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of IMS to ensure that the COI is resolved in order to ensure the integrity of the CME activity: for this CME activity, any COI has been resolved thru content review by IMS and/or Med-CE-online.com.
Faculty Disclosure: Timothy R. Wolfe, MD discloses that he is employed by Wolfe-Tory, and has a financial interest in Wolfe-Tory.
Disclosures of Educational Planners: Steven Sachse has received grants from Wolf-Torey Medical
The entire faculty for this program has reported that they will not discuss unapproved drug or device uses.
Commercial Support Disclosure: This program is supported by an educational grant from Wolf-Tory, a manufacturer of Medical Devices.
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.